2. Metabolic Enzyme/Protease Neuronal Signaling
  3. FAAH MAGL
  4. FAAH/MAGL-IN-2

FAAH/MAGL-IN-2 is a potent, reversible, orally active, and cross the blood-brain barrier FAAH and MAGL inhibitor with IC50s of 11 nM and 36 nM (Kis of 28 nM and 60 nM), respectively . FAAH/MAGL-IN-2 has the potential to research neuropathic pain without causing locomotion impairment.

For research use only. We do not sell to patients.

FAAH/MAGL-IN-2 Chemical Structure

FAAH/MAGL-IN-2 Chemical Structure

CAS No. : 2765077-82-3

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

FAAH/MAGL-IN-2 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

FAAH/MAGL-IN-2 is a potent, reversible, orally active, and cross the blood-brain barrier FAAH and MAGL inhibitor with IC50s of 11 nM and 36 nM (Kis of 28 nM and 60 nM), respectively . FAAH/MAGL-IN-2 has the potential to research neuropathic pain without causing locomotion impairment[1].

IC50 & Target

IC50: 11 nM (FAAH); 36 nM (MAGL)[1]
In Vitro

FAAH/MAGL-IN-2 (compound 14) (1, 3, 10, 30, 100 μM) shows potent neuroprotection effect[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

FAAH/MAGL-IN-2 Related Antibodies

Cell Cytotoxicity Assay[1]

Cell Line: SH-SY5Y cells
Concentration: 1, 3, 10, 30, 100 μM
Incubation Time: 24 h
Result: Showed potent neuroprotection effect.
In Vivo

FAAH/MAGL-IN-2 (10 mg/kg) has the potential to produce a significant anti-nociceptive effect without affecting of motor coordination and locomotor activity[1].
FAAH/MAGL-IN-2 (5, 10, 20 mg/kg) has the potential to treat neuropathic pain without causing locomotion impairment[1].
FAAH/MAGL-IN-2 (2000 mg/kg; p.o.; female rats) shows well tolerated and safe up to 2000 mg/kg in the oral dose and did not alter the liver enzymes activity[1].
FAAH/MAGL-IN-2 (20 mg/kg; p.o.) shows a good absorption behavior after oral administration[1].
Pharmacokinetic Parameters of JAK1/TYK2-IN-2 in 200–250 g, male Wistar rats[1].

200–250 g, male Wistar rats; 20 mg/kg; p.o.[1]
Pharmacokinetic parameters Results (Plasma)
Cmax (μg/mL) 22.04±2.5
Tmax (h) 0.5
AUC(0-t) (μg min/mL) 535±1.5
t1/2 (h) 20.58
MRT 0-inf (h) 0.5

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nerve-injured rats (CCI model)[1]
Dosage: 5, 10, 20 mg/kg
Administration:
Result: Significantly increased paw withdrawal threshold and attenuated tail flick latency in nerve injured rats.
Animal Model: 200–250 g, male Wistar rats[1]
Dosage: 20 mg/kg
Administration: Oral administration
Result: Showed a good absorption behavior after oral administration.
Molecular Weight

386.25

Formula

C15H13Cl2N3O3S
CAS No.
SMILES

O=C(N/N=C\C1=C(Cl)C=CC=C1Cl)NC2=CC=C(S(=O)(C)=O)C=C2
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

FAAH/MAGL-IN-2 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

FAAH/MAGL-IN-22765077-82-3FAAHMAGLFatty acid amide hydrolaseMonoacylglycerol lipaseLow toxicityreversibleorally activeBBBneuropathic painCCI modelInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
FAAH/MAGL-IN-2
Cat. No.:
HY-143264
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.